三氧自体输血的临床应用进展  

Progress in clinical application of autologous ozonized blood transfusion

作　　者：龙小琼 吴建君 赵树铭 LONG Xiaoqiong;WU Jianjun;ZHAO Shuming(Guiqian International General Hospital,Guizhou 550018,China)

机构地区：[1]贵黔国际总医院输血科,贵州贵阳550018

出　　处：《中国输血杂志》2023年第2期108-111,共4页Chinese Journal of Blood Transfusion

摘　　要：三氧自体输血是将血液在体外与医用三氧混合后,再回输到体内的1种治疗方法,已广泛应用于缺血、缺氧、自身免疫性疾病以及癌症的辅助治疗。三氧治疗的作用机制未完全明了,对治疗的三氧浓度、频次、疗程尚无统一标准,本文综述三氧自体输血的作用机制及临床应用进展。Autologous ozonized blood transfusion(AOBT)is a therapeutic method that mixes blood with medical ozone in vitro and then reinfuses it into the body.It has been widely used in the auxiliary treatment of ischemia,hypoxia,autoimmune diseases and cancer.The mechanism of ozone therapy is still unclear,and no unified standard for the concentration,frequency and course of AOBT treatment has been established.This article aims to review the mechanism and clinical application of AOBT.

关 键 词：三氧自体输血 作用机制 临床应用 

分 类 号：R457.1[医药卫生—治疗学] R459.6[医药卫生—临床医学]